BMY vs. LAC

Last updated Jun 13, 2026

BMY (Bristol-Myers Squibb Company) and LAC (Lithium Americas Corp.) are both stocks. BMY operates in Drug Manufacturers - General (Healthcare), while LAC operates in Other Industrial Metals & Mining (Basic Materials). Over the past year, BMY returned 20.57% vs 71.70% for LAC. At a 0.13 correlation, their price movements are largely independent.

Performance

BMY vs. LAC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bristol-Myers Squibb Company (BMY) and Lithium Americas Corp. (LAC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BMY achieves a 8.27% return, which is significantly higher than LAC's 4.36% return.

BMY

• 1D: 0.40%
• 1M: 0.23%
• YTD: 8.27%
• 6M: 11.43%
• 1Y: 20.57%
• 3Y*: 0.45%
• 5Y*: 0.73%
• 10Y*: 1.00%

LAC

• 1D: 3.17%
• 1M: -9.18%
• YTD: 4.36%
• 6M: -11.13%
• 1Y: 71.70%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BMY vs. LAC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
BMY Bristol-Myers Squibb Company	8.27%	0.11%	15.81%	-10.70%
LAC Lithium Americas Corp.	4.36%	46.80%	-53.59%	-27.19%

Correlation

The correlation between BMY and LAC is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (All Time) Calculated using the full available price history since Oct 2, 2023	0.13

Fundamentals

Market Cap BMY : $116.75B LAC : $1.61B
EPS BMY : $3.57 LAC : -$0.28
PB Ratio BMY : 5.82 LAC : 1.19
Total Revenue (TTM) BMY : $48.48B LAC : $0.00
Gross Profit (TTM) BMY : $33.33B LAC : -$580.22K
EBITDA (TTM) BMY : $13.34B LAC : -$52.10M

Return for Risk

BMY vs. LAC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMY

BMY Risk / Return Rank: 65
BMY Sharpe Ratio Rank: 65
BMY Sortino Ratio Rank: 61
BMY Omega Ratio Rank: 58
BMY Calmar Ratio Rank: 71
BMY Martin Ratio Rank: 70

LAC

LAC Risk / Return Rank: 69
LAC Sharpe Ratio Rank: 62
LAC Sortino Ratio Rank: 80
LAC Omega Ratio Rank: 76
LAC Calmar Ratio Rank: 66
LAC Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMY vs. LAC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and Lithium Americas Corp. (LAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BMY	LAC	Difference
Sharpe ratio: Return per unit of total volatility	0.68	0.56	+0.12
Sortino ratio: Return per unit of downside risk	1.18	2.21	-1.03
Omega ratio: Gain probability vs. loss probability	1.14	1.25	-0.11
Calmar ratio: Return relative to maximum drawdown	1.53	1.16	+0.37
Martin ratio: Return relative to average drawdown	3.32	1.77	+1.56

BMY vs. LAC - Sharpe Ratio Comparison

The current BMY Sharpe Ratio is 0.68, which is comparable to the LAC Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of BMY and LAC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BMY vs. LAC - Drawdown Comparison

The maximum BMY drawdown since its inception was -72.03%, smaller than the maximum LAC drawdown of -81.83%. Use the drawdown chart below to compare losses from any high point for BMY and LAC.

Drawdown Indicators

	BMY	LAC	Difference
Max Drawdown Largest peak-to-trough decline	-72.03%	-81.83%	+9.80%
Max Drawdown (1Y) Largest decline over 1 year	-12.05%	-63.08%	+51.03%
Max Drawdown (3Y) Largest decline over 3 years	-36.85%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-47.67%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-47.67%	—	—
Current Drawdown Current decline from peak	-17.79%	-61.18%	+43.39%
Average Drawdown Average peak-to-trough decline	-22.38%	-63.13%	+40.75%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.34%	41.47%	-35.13%

Volatility

BMY vs. LAC - Volatility Comparison

The current volatility for Bristol-Myers Squibb Company (BMY) is 8.22%, while Lithium Americas Corp. (LAC) has a volatility of 22.78%. This indicates that BMY experiences smaller price fluctuations and is considered to be less risky than LAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BMY	LAC	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.22%	22.78%	-14.56%
Volatility (6M) Calculated over the trailing 6-month period	18.18%	53.55%	-35.37%
Volatility (1Y) Calculated over the trailing 1-year period	27.08%	132.17%	-105.09%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.02%	101.55%	-77.53%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.29%	101.55%	-76.26%

Dividends

BMY vs. LAC - Dividend Comparison

BMY's dividend yield for the trailing twelve months is around 4.38%, while LAC has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BMY Bristol-Myers Squibb Company	4.38%	4.60%	4.24%	4.44%	3.00%	2.36%	3.69%	2.55%	3.08%	2.55%	1.95%	2.17%
LAC Lithium Americas Corp.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both BMY and LAC in my portfolio?

BMY and LAC have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BMY or LAC?

LAC has higher volatility (22.78%) compared to BMY (8.22%). In terms of maximum drawdown, BMY dropped -72.03% vs LAC's -81.83%.

Which has better risk-adjusted returns?

BMY currently has the higher Sharpe Ratio (0.68 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.